Free Trial

Trust Co. of Oklahoma Trims Holdings in Lam Research Corporation $LRCX

Lam Research logo with Computer and Technology background

Key Points

  • Trust Co. of Oklahoma trimmed its holdings in Lam Research Corporation by 38.2%, now owning 15,934 shares worth $1,551,000 as of its latest SEC filing.
  • Multiple analysts have recently raised their price targets for Lam Research, with Oppenheimer and UBS Group setting new targets of $120.00, reflecting a strong buy rating consensus.
  • Lam Research declared an increased quarterly dividend of $0.26 per share, up from the previous $0.23, highlighting a commitment to returning value to shareholders.
  • MarketBeat previews the top five stocks to own by October 1st.

Trust Co. of Oklahoma reduced its holdings in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 38.2% during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 15,934 shares of the semiconductor company's stock after selling 9,844 shares during the period. Trust Co. of Oklahoma's holdings in Lam Research were worth $1,551,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the business. Meridian Wealth Management LLC grew its holdings in shares of Lam Research by 1.4% during the first quarter. Meridian Wealth Management LLC now owns 9,732 shares of the semiconductor company's stock worth $707,000 after buying an additional 130 shares during the last quarter. GW&K Investment Management LLC raised its stake in Lam Research by 10.1% during the 1st quarter. GW&K Investment Management LLC now owns 1,534 shares of the semiconductor company's stock valued at $112,000 after acquiring an additional 141 shares during the last quarter. Dorsey & Whitney Trust CO LLC lifted its position in Lam Research by 1.2% during the 1st quarter. Dorsey & Whitney Trust CO LLC now owns 12,498 shares of the semiconductor company's stock worth $909,000 after acquiring an additional 146 shares during the period. Fiduciary Financial Group LLC grew its stake in shares of Lam Research by 3.8% in the 2nd quarter. Fiduciary Financial Group LLC now owns 4,073 shares of the semiconductor company's stock valued at $394,000 after purchasing an additional 150 shares during the last quarter. Finally, Citizens National Bank Trust Department increased its holdings in shares of Lam Research by 34.0% in the first quarter. Citizens National Bank Trust Department now owns 603 shares of the semiconductor company's stock valued at $44,000 after purchasing an additional 153 shares during the period. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Oppenheimer increased their price target on Lam Research from $110.00 to $120.00 and gave the stock an "outperform" rating in a report on Thursday, July 31st. Erste Group Bank began coverage on shares of Lam Research in a research note on Thursday, August 14th. They set a "buy" rating on the stock. UBS Group boosted their target price on Lam Research from $95.00 to $120.00 and gave the stock a "buy" rating in a research report on Monday, July 21st. Wall Street Zen raised Lam Research from a "hold" rating to a "buy" rating in a research note on Saturday, August 2nd. Finally, TD Cowen lifted their price target on Lam Research from $100.00 to $125.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. Twenty equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $107.96.

View Our Latest Stock Report on LRCX

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $116.96 on Friday. The business's 50 day simple moving average is $101.07 and its 200-day simple moving average is $86.72. The firm has a market capitalization of $148.03 billion, a price-to-earnings ratio of 28.12, a price-to-earnings-growth ratio of 1.49 and a beta of 1.76. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $117.50.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.12. The firm had revenue of $5.17 billion during the quarter, compared to the consensus estimate of $4.99 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.Lam Research's quarterly revenue was up 33.6% on a year-over-year basis. During the same period last year, the business posted $1.03 EPS. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. As a group, equities analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, September 24th will be paid a dividend of $0.26 per share. This is a boost from Lam Research's previous quarterly dividend of $0.23. The ex-dividend date of this dividend is Wednesday, September 24th. This represents a $1.04 annualized dividend and a dividend yield of 0.9%. Lam Research's dividend payout ratio is presently 22.12%.

Lam Research Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Featured Articles

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Biotech Stocks Under $5 With Huge Upside
Revealed: Congress’ Biggest Stock Moves This Month
He Said Sell Oracle. Here’s What Happened Next.

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines